THE US Food and Drug
Administration has issued a mass
recall of 359 different lots of Abbott
Diabetes Care’s glucose test strips.
The strips are used with Abbott’s
Precision Xceed Pro; Precision
Xtra; Medisense Optium; Optium;
OptiumEZ; and ReliOn Ultima
branded blood glucose meters.
The recall relates to certain lots of
the test strips manufactured
between January and September
2010 and distributed in the US and
Puerto Rico.
According to the FDA, the recall
is due to the test strips’ inability to
absorb enough blood for monitoring,
meaning that they may give falsely
low blood glucose results.
See www.fda.gov for details.The above article was sent to subscribers in Pharmacy Daily's issue from 24 Dec 10 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 24 Dec 10
MAYNE Pharma Group Limited has filed a patent infringement suit against Sun Pharmaceutical Industries Ltd and Inc., in the United States District Court, according to yesterday’s ASX announcement.
PHARMACY Connect 2024 conference will feature a provocative ‘Great Debate’ during the Harm Minimisation Workshop on Thu 05 Sep at the Hyatt Regency in Sydney.
LTR Pharma Limited has successfully raised $10.5 million through a share placement to sophisticated and new institutional investors, significantly surpassing initial demand.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.